Krystal Biotech (KRYS) to Offer $100M in Common Stock

Krystal Biotech Inc. (NASDAQ: KRYS) announced that it has commenced a $100 million underwritten public offering of its common stock. The Company intends to grant the underwriters a 30-day option to purchase an additional 15% of the shares of its common stock offered in the public offering. The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares to be sold in the proposed offering will be sold by the Company.

Goldman Sachs & Co. LLC, Cowen and Evercore ISI are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• Goldman Sachs Downgrades Shanghai Jahwa United (600315:CH) to Neutral
• QNB Corp. overallotment option adds 160,714 shares at $42 each